Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
WAVE Life Sciences Ltd. (WVE) had Free Cash Flow per Share of $-0.39 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$9.18M |
|
$-46.88M |
|
-- |
|
$9.18M |
|
$58.98M |
|
$-49.80M |
|
$2.93M |
|
$-46.88M |
|
$-46.88M |
|
$-46.88M |
|
$-46.88M |
|
$-46.88M |
|
$-46.88M |
|
$-49.80M |
|
$-47.64M |
|
162.53M |
|
162.53M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$257.98M |
|
$9.57M |
|
$30.37M |
|
$288.34M |
|
$87.37M |
|
-- |
|
$29.17M |
|
$116.54M |
|
$171.80M |
|
$171.80M |
|
$171.80M |
|
154.09M |
|
| Cash Flow Statement Financials | |
$-63.04M |
|
$-0.17M |
|
$4.16M |
|
$305.84M |
|
$246.85M |
|
$-58.99M |
|
$4.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-542.82% |
|
-542.82% |
|
-- |
|
-510.93% |
|
-510.93% |
|
$-63.20M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-27.29% |
|
-27.29% |
|
-16.26% |
|
-27.29% |
|
$1.11 |
|
|
Free Cash Flow per Share |
$-0.39 |
$-0.39 |
|